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Introduction
Sleep complaints and disruptions in the sleep-wake cycle are common in older people. Over 50% of adults aged over 65 have at least one chronic sleep-related problem with high rates of sleep apnoea, insomnia and restless legs [1, 2] . Changes in circadian rhythms can be demonstrated with advancing age, with a decline in the cortisol and melatonin rhythms that entrain day-night activity patterns [3, 4] . With ageing there is reduced amplitude of the circadian rhythm, a phase shift (in particular phase advance) [5] and a loss of the robustness of the rhythm. However, within older populations there is significant variability between individuals with some hypothesising an age-related disruption to the suprachiasmatic nucleus [6] .
Poor sleep in older adults is associated with an increase in mortality, accidents and falls and a decline in health status [2] . There is a particular association between disrupted circadian rhythms and dementia [7] . For the very old, variously defined as those aged 80+ or 85+, sleep and circadian rhythm data are limited yet these are now the fastest growing age sector of the population [8] .
We have assessed the sleep and wake patterns of a large, well characterised UK cohort of people aged 87-89 years, including in institutional care, and report the extent of sleep disorders, the contribution of different diseases and conditions to disrupted sleep and whether very old individuals with sleep disorders have a higher risk of mortality.
Methods Participants
The study was nested in the Newcastle 85+ Study, a population-based longitudinal study of health and ageing in the very old [9] . People living in Newcastle or North Tyneside (NE England) were recruited at around age 85 through general practitioner patient lists; those living in institutions and the cognitively impaired were included. Following baseline assessment (Phase 1: 2006-7, n = 849) Newcastle 85+ Study participants were re-assessed at 18 months (Phase 2: 2007-9, n = 630) and again at 36 months (Phase 3: 2009-10, n = 484). Loss between phases 1 and 3 was mainly due to deaths (63.6%, 232/365) with the remainder due to drop out. Participants were invited to take part in this sleep study as part of the 36-month followup assessment when participants were aged 87-89 years. All assessments were conducted in the participant's usual residence (home or institution). Ethical approval was obtained from Newcastle and North Tyneside Local Research Ethics Committee. Written informed consent was obtained from participants and where people lacked the capacity to consent, a formal written opinion was sought from a relative/carer in accordance with the UK Mental Capacity Act [10].
Sleep questionnaires
A research nurse administered the Pittsburgh Sleep Questionnaire Inventory (PSQI) [11] and the Epworth Sleepiness Score (ESS) [12] as subjective measures of sleep and wake. These well-validated questionnaires assess sleepwake disturbance and daytime sleepiness, respectively.
Accelerometry measures
Participants wore a triaxial accelerometer (GENEA, Unilever) on their right wrist continuously for a period of 5-7 days within their normal home environment. The GENEA records continuous acceleration rather than epoch-based summary measures more typical of studies employing commercial actiwatches (actigraphy) and has been validated for monitoring activity levels [13] . Only participants who had worn the watch continuously for 5 days or more within the 7-day period were included in the analysis. In those with seven full days of monitoring, 5 and 7 day measures were compared and no significant differences were found.
The following accelerometry measures were obtained: the least active 5 h period (L5); the most active 5 h period (M5); the mean rest-active transition count in the least active 5 h (L5_TN) and the difference between M5 and L5 (ΔM5L5). L5 and M5 activity counts were averaged for the entire 5-day period.
Participants were divided into quartiles for each accelerometry measure and then the middle two quartiles were grouped together to represent low, medium and high activity counts for all the subsequent analyses. We investigated three objective measures of sleep disturbance, defining abnormal sleep patterns as those in the lowest quartile of ΔM5L5and the highest quartiles of L5 and L5_TN.
Morbidity and mortality measures
Measures assessed for association with sleep disorders were those indicated in younger populations: disability (difficulties in 17 daily activities coded as 0 difficulties/1-6/7-12/13-17), depressive symptomatology using the Geriatric Depression Scale (ref) and coded as none/mild/severe, cognition assessed by the Mini-Mental State Examination (MMSE), number of falls in last year (none/1/2/3+) and body mass index (BMI), (assessed at 36 months). Data on pre-existing diseases were extracted from the general practice medical records and included presence at baseline, of ischaemic heart disease, arthritis, cerebrovascular disease, cancer (excluding non-melanoma skin cancer) in last 5 years, chronic obstructive airways disease, as well as a total chronic disease count (18 diseases and conditions coded as none/1-2/3-6/7+) [9] . The National Health Service Medical Research Information Service provided the date of death. Survival time was measured from date of actigraphy to death or censored at 1/8/2011 (mean follow-up 24 months).
Statistical analysis
Associations between measures of disturbed sleep and sociodemographic and health characteristics of participants were assessed by Mann-Whitney U tests (ESS, PSQI) or KruskalWallis tests (accelerometry measures in three categories) for ordinal data (disability score, disease count, depression, BMI, self-rated health, MMSE, number of falls) and Chi-square tests for categorical variables (sex, where living, presence of individual diseases). The associations between accelerometry measures of disturbed sleep and subjective measures (ESS and PSQI scores) were assessed by Kruskal-Wallis tests. The impact of objective and subjective sleep measures on subsequent survival was investigated by Cox proportional hazards regression models with adjustment initially for sex, then added disease count, disability, cognitive function and BMI. P-values were two-sided; the level of significance was 0.05. Missing values were excluded from the data set and percentages were calculated from the number of valid responses.
Results

Sleep questionnaires
Four hundred and twenty-seven/484 participants completed both PSQI and ESS questionnaires without any missing data; 63.5% were women (156 men: 271 women), the majority (80.3%) lived independently at home, 41% rated their health as excellent or very good, 7.3% had no difficulty with activities of daily living and 69.9% had no cognitive impairment (MMSE score 26-30). Some disturbance of sleep (PSQI >5) was reported by 50.1% although only 15.7% had severe sleep disturbance (PSQI >10). Daytime sleepiness (ESS >10) was reported by only 10.8% (Supplementary data are available in Age and Ageing online, Table S1 ).
Those reporting disturbed sleep (PSQI >5) were more likely to be female, to report poorer self-rated health, to have depressive symptomatology, were less likely to have cerebrovascular disease but had a similar prevalence of other diseases, disability, cognitive impairment and obesity as participants not experiencing disturbed sleep (Supplementary data are available in Age and Ageing online, Table S2 ). Participants who had significant daytime sleepiness (ESS >10) were more likely to have higher levels of disability and depressive symptomatology than those without daytime sleepiness (Supplementary data are available in Age and Ageing online, Table S3 ).
Accelerometry
Of the 427 participants with complete sleep scores, 337 (79%) wore the accelerometer for at least five continuous days. When compared with those with accelerometry data (n = 337, 130 M: 207 F), those without accelerometry (n = 90) were more likely to live in an institution (χ 2 , P < 0.001), more disabled (Mann-Whitney U, P = 0.003), had worse cognitive function (Mann-Whitney U, P < 0.001) and reported more falls (Mann-Whitney U, P = 0.04) although PSQI and ESS scores were similar (data not shown).
Accelerometry provided a clear representation of daily activity and a robust assessment of sleep-wake cycles with decreased activity during the night and increased activity during the day. There was marked variation between participants, with some individuals being much more active during the day and demonstrating much greater differences between day and night time activity patterns. Data from two participants are shown in Figure 1 . Although the total amount of physical activity varies between the two individuals, it is possible to distinguish a sleep-wake pattern in both.
Association between accelerometry measures of disturbed sleep and subjective sleep measures Of the objective measures of abnormal sleep patterns only ΔM5L5 was associated with significantly higher ESS scores (Mann-Whitney U test, P < 0.007), most participants reporting daytime sleepiness having little difference in levels of activity between the most and least active 5 h (low ΔM5L5) (Supplementary data are available in Age and Ageing online, Table S4 ). In addition participants reporting daytime sleepiness were significantly more likely to have low activity levels in the most active 5 h (low M5) (Mann-Whitney U test, P = 0.012). The global PSQI score was not significantly associated with any of the accelerometry measures of disturbed sleep (Supplementary data are available in Age and Ageing online, Table S4 ), although those with poorer sleep quality (PSQI component 1) were significantly more likely to have higher activity levels in the least active 5 h (high L5 activity) (KruskalWallis test, P = 0.014) (data not shown).
Association between accelerometry measures of disturbed sleep and other health parameters
Participants with abnormal sleep-wake cycles defined by little difference in activity between the most and least active periods (ΔM5L5) were significantly more likely to have poorer cognitive function, depressive symptomatology, more falls, be obese, arthritis, higher disease count and more disability ( Table 1) . Neither of the two other objective measures of sleep abnormality (L5 and L5_TN) appeared to be significantly associated with sociodemographic characteristics, disease burden or functioning.
Subjective and objective measures of sleep and mortality
Only abnormal sleep-wake cycles, defined by ΔM5L5, was significantly associated with reduced survival after adjustment for sex (P = 0.002). After further adjustment for disability, cognitive function, disease count and BMI ΔM5L5 remained significantly associated with subsequent 2-year mortality (P = 0.018) (Figure 2) , participants with abnormal sleep-wake cycles (low ΔM5L5) having over 3 times the risk of death (hazard ratio: 3.18, 95% CI: 1.25-8.09) compared with participants having high differentiation between active and inactive periods (high ΔM5L5). Neither of the two other objective measures or the subjective measures were significantly associated with survival (L5: P = 0.91; L5_TN P = 0.23; PSQI: P = 0.77; ESS P = 0.18).
Discussion
This population-based study is the first to subjectively and objectively assess the sleep and circadian rhythms of a UK cohort of very old people (87-89 years) and report the relationship with morbidity, functioning and mortality. Significantly disturbed sleep (PSQI >10) was reported by only 16% of the very old and significant daytime sleepiness by only 10.8%. Depressive symptomatology was higher in those with disturbed sleep and those with daytime sleepiness but no other disease or cognitive impairment was significantly associated with the presence of reported sleep disorders.
In contrast, very old people with disturbed sleep-wake cycles, objectively assessed using accelerometry, were more likely were had significantly worse cognitive function, higher BMI, more falls, more depressive symptoms, and were more likely to have arthritis and a higher number of diseases in total. We found no evidence of association between the objective and subjective measures of sleep disturbance with the exception of the difference in activity levels between the most and least active periods (ΔM5L5) and the ESS. However, participants with little difference in activity between the most and least active periods (ΔM5L5) had significantly worse survival even after adjustment for potential confounding factors.
Previous studies have suggested that the ESS and PSQI reliably detect sleep disturbance in adults over 60 both alone and with both polysomnography and accelerometry [14] [15] [16] . In these studies, the PSQI was better than the ESS at distinguishing those with normal sleep from those with sleep disorders. Raised PSQI score was associated with female sex and depressive symptoms, and this was confirmed by our study. Other studies have demonstrated that the PSQI and ESS correlate poorly with objective measures of sleep assessment in older populations [17] . There was only a weak association between proven sleep apnoea and elevated ESS in the large MrOS cohort study (mean age of 75.6) and no association with PSQI [18, 19] . In the MrOS study 13% of men had ESS >10 which matches the low reporting of significant sleep disturbance in our cohort (16% PSQI >10 and 11% ESS >10). There are a number of possible explanations for low reporting of subjective sleep disturbance: this population may have different expectations of sleep and wake; cognitive impairment may have affected the accurate completion of the questionnaires and the large number of participants who lived and slept alone may have affected accurate reporting for Figure 1 . Accelerometry Data. Accelerometry data over a 7-day period of continuous recording with two different participants. Both participants have cycles of decreased activity corresponding to a sleep period (marked with arrow) and increased activity during wake. However, the total amount of activity varies between the two participants. some responses. Our results suggest that these widely used screening tools do not accurately identify disrupted sleep and wake measured more objectively in the very old, although our findings of associations between sleep disturbance and both female gender and depressive symptoms confirm these across a broader age range.
Accelerometry or actigraphy has been used to assess sleep and wake patterns for many years and is well established in both clinical practice and research (for review 20) . Early studies across community-based populations described the increasingly fragmented sleep that occurred during ageing, with a tendency for older subjects to have an advanced sleep phase compared with younger subjects in several large population studies [3, 5] . Limitations of previous studies include the variability and lack of standardisation of analysis methods, although many use non-parametric circadian rhythm analysis. This is the first study to use continuous wave accelerometry in a very old population; this technique allows for analysis of raw data enabling systematic exploration of alternative measures with potentially greater sensitivity appropriate for a group with reduced total physical activity. By far the largest studies using accelerometry in the elderly to date has been the US, multicentre MrOS and SOF studies that recruited over 6,000 community-dwelling men and women over 67 years of age and used at least five or more days of accelerometry to assess rest activity rhythms and sleep-wake cycles in relation to a wide variety of health parameters. In women (mean age 83.5 years) actigraphically measured disturbed sleep was consistently related to poorer cognition although total sleep time was not [21] . A subset of younger participants (mean age 67.5) were followed up for 3.5 years and a small but definite association between disturbed rest/activity rhythms and increased all-cause and cardiovascular mortality was found [22] . In men, there has recently been an association described between frailty, poor objective sleep measures and increased mortality [23] . In our cohort, we found reduced survival in those with abnormal sleep-wake cycles and decreased activity during the most active period of the day (M5).
Strengths of the study included its population-based sample allowing assessment of those living independently and within institutions, and those with cognitive impairment. Obtaining information on diseases from medical records increased data reliability [9] . The novel triaxial accelerometer allowed greater sensitivity in data analysis compared with existing commercial devices. Our study has some limitations: few participants had abnormal PSQI and ESS which reduces our ability to detect weaker associations; sleep diaries were not completed alongside accelerometry which may have further informed causes of fragmented sleep, though this was likely to have overburdened very old adults and reduced study participation. Finally, both sleep questions and accelerometry were only included in the 3-year follow-up when participants were aged 87-89. However, the baseline cohort was broadly representative of 85 year olds in England and Wales [9] and as the main reason for withdrawal from the study was death, the surviving cohort should also be representative of 87-89 year olds.
In conclusion, reported sleep disturbance affects a minority of the very old. However, these commonly used sleep questionnaires do not differentiate well between those normal and abnormal sleep-wake cycles determined objectively.
This study confirms that objectively measured, abnormal sleep-wake cycles are strongly correlated with cognitive impairment, depressive symptoms, falls, higher BMI and arthritis (and higher number of diseases in total) and also with increased mortality in the very old.
Key points
• Primary sleep disorders are common and increase with age.
• The 85+ report little subjective sleep disturbance.
• Objective sleep disturbance measured with actigraphy is common.
• Objective sleep disturbance is associated with increased mortality.
